nir-vana innovation network

The Russian research company from the Novosibirsk region was founded in 2010. The company specializes in the sphere of biotechnological products, develops, manufactures, and sells products for research and biotechnological activities and related services. Since that time every year, the company increases the number of sales and a variety of products.

The company's products are reagents for research in the following areas: molecular biology, genetic engineering, biochemistry.
The company produces a wide range of biotechnological products: kits for amplification of nucleic acids, Deoxyribonucleic acid (DNA) markers, kits for extraction of Ribonucleic acid (RNA), a wide range of antibodies, and other biotechnological products in different types of assembly and packaging. The company’s DNA marker is supplied ready to use in a storage buffer containing 12.5% ​​glycerol, 0.008% bromophenol blue, 0.008% xylene cyanol.
Because of using its own ferments and triphosphates during manufacture, the company can offer lower prices than competitors on the global market, and it ensures high quality and reproducibility of results.
All the reagents are simple in use because of stability (mixes for polymerase chain reaction (PCR) don’t lose the effectiveness after 30 days at room temperature) and optimal packaging. There are also PCR-kits protected from cross-contamination due to inclusion in the reaction of mixture Deoxyuridine Triphosphate (dUTP) and Uracil DNA glycosylase. The company produces a modern device for the study of nucleic acids and proteins. The device is ideal for measuring nucleic acid concentrations in preparation for PCR, sequencing, cloning, various kinds of transfections, etc. Calibration standards 200 ng / μl and 5 ng / μl.
Today the company has developed a reagent kit for the qualitative detection of coronavirus 2019-nCoV or SARS-CoV-2 RNA
The company's products are presented on the European market and are used in laboratories. The kit includes two primer systems: a screening system (N gene) and a system for confirming (ORF1b gene) positive results.
This technology uses a reverse transcription reaction to convert RNA into complementary DNA. The kit is intended for research purposes only.
The company's products are bought in Russia, Kazakhstan, Germany, the USA, Italy, the Czech Republic and other countries of the world.

The company is looking for partners from the medical sphere, trade, or research companies to conclude a distribution services agreement. In accordance with the distribution services agreement, the Russian company will supply its products to partners. In turn, a foreign partner will distribute Russian products in the foreign market.
The expected result of this cooperation for the Russian company is the expansion of its position in the foreign market as well as the receipt of additional profit.

Advantages & innovations

- At the company's warehouse, there are always the most requested goods for equipping laboratories, which the company will deliver as soon as possible. - A constant exchange of information with leading laboratories (DNA Technology, Litekh, Vector-Best, Sileks, Eurogen) and medical universities allows the company to keep abreast of the latest advances in the creation of reagents for research in the field of molecular biology, PCR analysis, and immunobiology. - The company offers customized services and products, consulting, and aftersale services. - The company annually takes part in the International Exhibition of Innovative Laboratory Equipment and Laboratory Process Optimization, which takes place in Germany.

Stage of development

Already on the market

Partner sought

Type: SME’s, large companies, companies selling medical equipment, reagents, trade companies. Role: In the framework of distribution services agreement the partner will help the Russian company distribute its products in the foreign market.